Search research articles
Contact Us
Filters
Showing results (41-50 of 181) with videos related to
Page
of 19
Sort By:
Transplantation Proceedings
|
September 20, 2017
Mycophenolate Mofetil Withdrawal With Conversion to Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients
D Wojciechowski, S Chandran, A Webber, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia
|
April 16, 2008
[Dysphonia and cacosmia in a worker in sterilized rooms]
N Magnavita, P Bordignon, G Ciaffi, et al.
The American Journal of Medicine
|
October 1, 1982
Urinary kallikrein excretion after renal transplantation: relationship to hypertension, graft source, and renal function
D T O'Connor, A P Barg, W Amend, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association
|
January 1, 1979
Pretransplant cytotoxic antibodies do not segregate kidney transplant recipients into responder and non-responder groups
F Vincenti, W Amend, N Feduska, et al.
Archives of Internal Medicine
|
April 1, 1982
Blood transfusions and kidney transplantation
F Vincenti, W J Amend, N J Feduska, et al.
Transplantation Proceedings
|
March 26, 2004
Optimizing the use of cyclosporine (Neoral) for recipients of living donor kidneys
F Vincenti, T V Brennan, T F Fuller, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1981
Furosemide kinetics and dynamics after kidney transplant
D E Smith, J G Gambertoglio, F Vincenti, et al.
Lancet (London, England)
|
June 18, 1977
Hepatitis-B reactivation after renal transplantation
A E Denes, K R Berquist, H A Fields, et al.
Transplantation Proceedings
|
February 1, 1995
Phase II FK 506 multicenter concentration control study: one-year follow-up
D A Laskow, F Vincenti, J Neylan, et al.
Annals of Internal Medicine
|
September 1, 1979
The transplanted kidney as a source of hepatitis B infection
J L Wolf, H A Perkins, M T Schreeder, et al.
Page
of 19
Search research articles
Search
Showing results (41-50 of 181) with videos related to
Sort By:
Page
of 19
Transplantation Proceedings
|
September 20, 2017
Mycophenolate Mofetil Withdrawal With Conversion to Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients
D Wojciechowski, S Chandran, A Webber, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia
|
April 16, 2008
[Dysphonia and cacosmia in a worker in sterilized rooms]
N Magnavita, P Bordignon, G Ciaffi, et al.
The American Journal of Medicine
|
October 1, 1982
Urinary kallikrein excretion after renal transplantation: relationship to hypertension, graft source, and renal function
D T O'Connor, A P Barg, W Amend, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association
|
January 1, 1979
Pretransplant cytotoxic antibodies do not segregate kidney transplant recipients into responder and non-responder groups
F Vincenti, W Amend, N Feduska, et al.
Archives of Internal Medicine
|
April 1, 1982
Blood transfusions and kidney transplantation
F Vincenti, W J Amend, N J Feduska, et al.
Transplantation Proceedings
|
March 26, 2004
Optimizing the use of cyclosporine (Neoral) for recipients of living donor kidneys
F Vincenti, T V Brennan, T F Fuller, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1981
Furosemide kinetics and dynamics after kidney transplant
D E Smith, J G Gambertoglio, F Vincenti, et al.
Lancet (London, England)
|
June 18, 1977
Hepatitis-B reactivation after renal transplantation
A E Denes, K R Berquist, H A Fields, et al.
Transplantation Proceedings
|
February 1, 1995
Phase II FK 506 multicenter concentration control study: one-year follow-up
D A Laskow, F Vincenti, J Neylan, et al.
Annals of Internal Medicine
|
September 1, 1979
The transplanted kidney as a source of hepatitis B infection
J L Wolf, H A Perkins, M T Schreeder, et al.
Page
of 19